Table 1.
Strategy Targets | Measures | Evidence-based Examples | Pros/Cons |
---|---|---|---|
RA control |
Disease activity | E.g. Treat-to-Target: Reducing inflammation improves CVD risk and outcomes in multiple trials [14–17] | Pro: Leverages rheumatologist expertise |
Con: Overlooks other modifiable risk factors | |||
Individual risk |
Framingham or SCORE calculation with 1.5 multiplier | E.g. 30 minute nurse visits for CVD risk assessment identified many new risk factor diagnoses (e.g. new diabetes in 14%) [49] | Pro: Comprehensive |
Con: Resource intensive | |||
Population risk |
Hypertension (BP) Smoking status Cholesterol Diabetes (A1C) Obesity (BMI) Inactivity |
E.g. Staff protocols increased blood pressure control from 50% to 80% in a health maintenance organization [61] | Pro: Broad reach, empowers non-MD staff |
Con: Targets specific risk factors, not comprehensive |